Single-cell RNA sequencing reveals the unique tumor microenvironment of small cell neuroendocrine carcinoma of the ovary

Small cell neuroendocrine carcinoma of the ovary (SCNECO) is a rare and highly ​aggressive malignancy characterized by early metastasis, high recurrence rates, and poor prognosis. Here, we present a single-case, detailed single-cell transcriptomic profiling of this cancer, which remains largely unexplored at this resolution. Our gene regulatory network analysis suggested that high HOXB2 expression correlates with unfavorable patient outcomes. HOXB2 was markedly upregulated during the later stages of neuroendocrine carcinoma progression and was associated with the maintenance of the neuroendocrine phenotype in our data. Furthermore, our data are consistent with the possibility that the neuroendocrine marker genes and their associated regulatory networks in SCNECO differ from those in pulmonary neuroendocrine carcinomas as documented in the Gene Expression Omnibus (GEO) database, supporting a tissue-specific origin for these malignancies, which remains to be confirmed in larger, independent cohorts. Collectively, this work addresses a critical gap in the understanding of SCNECO and provides preliminary, hypothesis-generating insights that may guide future studies on chemotherapy, targeted therapy, and immunotherapy approaches.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-13
DOI
https://doi.org/10.1186/s12885-026-17344-w
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Single-cell RNA sequencing reveals the unique tumor microenvironment of small cell neuroendocrine carcinoma of the ovary

Weige Zhou, Y F LIU, Xiaobao Cao, Ying He et al.
5 links
BMC Cancer
Neuroendocrine Tumor Research Advances
article

Single-cell RNA sequencing reveals the unique tumor microenvironment of small cell neuroendocrine carcinoma of the ovary

Weige Zhou, Y F LIU, Xiaobao Cao, Ying He, Yu Guo, Guangting Xie, Li Sun, Kang Ouyang
article en

Abstract

Small cell neuroendocrine carcinoma of the ovary (SCNECO) is a rare and highly ​aggressive malignancy characterized by early metastasis, high recurrence rates, and poor prognosis. Here, we present a single-case, detailed single-cell transcriptomic profiling of this cancer, which remains largely unexplored at this resolution. Our gene regulatory network analysis suggested that high HOXB2 expression correlates with unfavorable patient outcomes. HOXB2 was markedly upregulated during the later stages of neuroendocrine carcinoma progression and was associated with the maintenance of the neuroendocrine phenotype in our data. Furthermore, our data are consistent with the possibility that the neuroendocrine marker genes and their associated regulatory networks in SCNECO differ from those in pulmonary neuroendocrine carcinomas as documented in the Gene Expression Omnibus (GEO) database, supporting a tissue-specific origin for these malignancies, which remains to be confirmed in larger, independent cohorts. Collectively, this work addresses a critical gap in the understanding of SCNECO and provides preliminary, hypothesis-generating insights that may guide future studies on chemotherapy, targeted therapy, and immunotherapy approaches.

BMC Cancer
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), BGI Research (CN), Guangzhou Laboratory (CN)
Good health and well-being
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon